Cardiron

Cardiron is a startup that aims to revolutionize healthcare for elderly heart failure patients. Founded in 2019, the company is committed to providing intensive healthcare using a non-intrusive platform and patented questioning method. With a significant portion of heart failure costs in the Netherlands attributed to women over 80 years old, amounting to approximately 380 million annually, Cardiron addresses both the financial need and the burden of disease. The team, consisting of experienced cardiologists, has developed a prototype platform that integrates sensor technology with data transmission to family or healthcare workers, enabling timely intervention and minimizing unnecessary medical visits. They plan to partner with academic institutions and a teaching hospital to create a reliable and cost-effective solution that promotes better health outcomes while reducing costs. In terms of funding, Cardiron is seeking a 3 million investment to obtain licensing, CE marking, and scale up production. The company believes that with this investment, they can successfully penetrate a lucrative market. Their innovative approach, coupled with the potential for significant market share in the multibillion-dollar healthcare industry, makes Cardiron an attractive investment opportunity for venture capitalists.